CD437 (AHPN) is a naphthoic acid derivative that functions as a selective agonist of the retinoic acid receptor gamma. It is investigated for its ability to induce cell cycle arrest and apoptosis in various cancer cell models.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 125316-60-1
Methyl 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthoate
pharmaceutical raw material
Vinorelbine L-tartrate
pharmaceutical raw material
Docetaxel
active pharmaceutical ingredient
Netarsudil
pharmaceutical raw material
Gilteritinib
pharmaceutical raw material
Adapalene
pharmaceutical intermediate
6-(3-(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)-4-methoxyphenyl)naphthalene-2-carboxylic acid
pharmaceutical intermediate
Mehtyl 6-[3-(1-adamanty)-4-methoxy phenyl]-2-naphthoate
pharmaceutical intermediate
6-[3-(1-adamantyl)-4-hydroxyphenyl]naphthalene-2-carboxylic acid
LDGIHZJOIQSHPB-UHFFFAOYSA-N
C1C2CC3CC1CC(C2)(C3)C4=C(C=CC(=C4)C5=CC6=C(C=C5)C=C(C=C6)C(=O)O)O